Leerink, Oppenheimer, H. C. Wainwright, Roth, JonesTrading will assist
By Devika Patel
Knoxville, Tenn., May 26 – OvaScience, Inc. said it priced a $50.05 million public offering of stock with a $7.51 million greenshoe. The offering was announced Wednesday.
The company sold 7.15 million common shares at $7.00 per share. The price per share is a 28.43% discount to the May 25 closing share price of $9.78.
Leerink Partners, LLC is the bookrunner.
Settlement is expected June 1.
Proceeds will be used for the commercial expansion of the Augment treatment, pre-commercial activities and working capital and other general corporate purposes.
Based in Cambridge, Mass., OvaScience is a fertility company focused on new treatments for infertility.
| Issuer: | OvaScience, Inc.
|
| Issue: | Common stock
|
| Amount: | $50.05 million
|
| Greenshoe: | $7,507,500, or 1,072,500 shares
|
| Shares: | 7.15 million
|
| Price: | $7.00
|
| Warrants: | No
|
| Bookrunner: | Leerink Partners LLC
|
| Co-managers: | Oppenheimer & Co. Inc., H. C. Wainwright & Co., Roth Capital Partners, LLC and JonesTrading Institutional Services LLC
|
| Announcement date: | May 25
|
| Pricing date: | May 26
|
| Settlement date: | June 1
|
| Stock symbol: | Nasdaq: OVAS
|
| Stock price: | $9.78 at close May 25
|
| Market capitalization: | $194.71 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
